Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2023-02-13
2023-11-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Diabetes Medication Adherence for African Americans in Madison and Milwaukee Through Peer Support
NCT04028076
A Family Dyad-focused Diabetes Self-Management Intervention for African American Adults
NCT05905575
Partners in Care Diabetes Self-management Intervention
NCT01235429
Peer-Supported Diabetes Self-Management Support
NCT02746861
Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST)
NCT02722499
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The new program is culturally-tailored for African Americans and focuses on helping patients take their medicines as prescribed.
The purpose of this research study is to evaluate this newly developed combined diabetes self-management program.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Living with Diabetes (HLWD)
Participants will have a 6-week self-management program, followed by the option to work with a Community Health Worker for the remaining 4 months.
HLWD
Weekly group sessions for two months. Sessions will last up to 2.5 hours and focus on a different diabetes self-management topic.
Peers EXCEL
Participants will have an 8-week self-management program, and will participate in phone calls with a peer for the remaining 4 months.
Peers LEAD
Two group session focusing on beliefs about medicines and diabetes, discrimination/mistrust, and communication with providers, and 2 peer-based phone calls from Ambassadors to occur weekly for weeks 3-8, then bi-weekly for weeks 9-12.
HLWD
Weekly group sessions for two months. Sessions will last up to 2.5 hours and focus on a different diabetes self-management topic.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peers LEAD
Two group session focusing on beliefs about medicines and diabetes, discrimination/mistrust, and communication with providers, and 2 peer-based phone calls from Ambassadors to occur weekly for weeks 3-8, then bi-weekly for weeks 9-12.
HLWD
Weekly group sessions for two months. Sessions will last up to 2.5 hours and focus on a different diabetes self-management topic.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-identify as African-American
* Diagnosis of Type 2 diabetes
* Able to speak/read English
* Self-report having a primary care provider who prescribes one diabetes medication
* Diagnosed with diabetes for ≥1 year at point of care
* Will reside in the geographical area throughout the study period
* Self-reported nonadherence on the DOSE-nonadherence survey
* ≥7.5% A1C
Exclusion Criteria
* Older adults who have a history of severe hypoglycemia requiring medical assistance or glucagon administration
* Participating in another lifestyle or medication adherence program
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olayinka Shiyanbola, MD
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wisconsin
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A561000
Identifier Type: OTHER
Identifier Source: secondary_id
PHARM/PHARMACY
Identifier Type: OTHER
Identifier Source: secondary_id
Protocol Version 02/20/2023
Identifier Type: OTHER
Identifier Source: secondary_id
2022-0879
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.